About LevitasBio
LevitasBio is a private company based in Menlo Park, California. It has reported $73,770,823 raised in four offerings on Form D since August 2017. Its chief executive is Martin Pieprzyk.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 28, 2024 | Apr 10, 2024 | $11,759,181of $25.0M target | 3 | $3.9M | EquityRule 506(b) | Form D ↗ |
| Sep 12, 2022 | Oct 26, 2022 | $34,999,997fully sold | 4 | $8.7M | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2020 | Jan 15, 2021 | $19,011,644of $24.0M target | 5 | $3.8M | EquityRule 506(b) | Form D ↗ |
| Jul 27, 2017 | Aug 3, 2017 | $8,000,001fully sold | 1 | $8.0M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $73,770,823 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on LevitasBio's Form D filed Apr 10, 2024.
ST
Steve Tablak
Director
PM
Paul Meister
Director
GH
Greg Herrema
Director
SG
Sandy Gardiner
Director
MP
Martin Pieprzyk
Chief Executive Officer and director
VJ
Victor Tong, Jr.
Director
Earlier filings also listed Zheng Wang (director, last listed Jan 2021), Xiangmin Cui (director, last listed Jan 2021), Lars Steinmetz (director, last listed Jan 2021) and Utkan Demirci (director, last listed Aug 2017).